- Home
- LSF vs HIND Comparison
LSF vs HIND Comparison
Compare LSF & HIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LSF | HIND |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.3M | 28.0M |
| IPO Year | 2020 | 2016 |
Fundamental Metrics
Financial Performance| Metric | LSF | HIND |
|---|---|---|
| Price | $2.31 | $5.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 118.3K | N/A |
| Earning Date | 11-10-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $48,146,862.00 | N/A |
| Revenue This Year | $18.05 | N/A |
| Revenue Next Year | $17.53 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 17.73 | N/A |
| 52 Week Low | $2.18 | N/A |
| 52 Week High | $8.99 | N/A |
Technical Indicators
Market Signals| Indicator | LSF | HIND |
|---|---|---|
| Relative Strength Index (RSI) | 28.90 | 59.52 |
| Support Level | $2.18 | $4.81 |
| Resistance Level | $2.78 | $5.37 |
| Average True Range (ATR) | 0.19 | 0.42 |
| MACD | 0.05 | 0.07 |
| Stochastic Oscillator | 27.67 | 86.81 |
Price Performance
Historical ComparisonAbout LSF Laird Superfood Inc.
Laird Superfood Inc is engaged in the business of manufacturing and marketing differentiated plant-based and functional foods. The product portfolio includes Coffee creamers, Hydration products and beverage-enhancing supplements, Harvest snacks and various other food items, and Coffee, tea, and hot chocolate products.
About HIND Vyome Holdings Inc.
Vyome Holdings Inc is a reseach and development company. The Company operates in two segments, biotechnology and pharmaceutical products. The biotechnology segment comprises of operations around VT-1953, VT-1908, and VB-1953 programs that are in development, and the pharmaceutical segment comprises of antifungal products manufacturing and distribution.